The Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

doi:10.1056/NEJM200105313442214

Volume 344:1720-1721		May 31, 2001		Number 22

The Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

Full Text

PDF

Purchase this article

Add to Personal Archive

Add to Citation Manager

Notify a Friend

E-mail When Cited

PubMed Citation

To the Editor: The report by McClung et al. (Feb. 1 issue)¹is unconvincing, because information is not presented to showthat the women in the treatment and placebo groups had similarclinical risk factors for hip fracture. This information shouldhave been included in the table showing the base-line characteristicsof the groups.

Paul C. Royce, M.D., Ph.D.
9 Prospect Rd.
Atlantic Highlands, NJ 07716

References

McClung MR, Geusens P, Miller PD, et al. Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 2001;344:333-340. [Free Full Text]

To the Editor: McClung et al. state that "complete follow-updata were available for 64 percent of the women." In other words,follow-up data were incomplete for 36 percent, or 3324, of the9331 . . . [Full Text of this Article]

This article has been cited by other articles:

Giebink, G. S. (2001). The Prevention of Pneumococcal Disease in Children. NEJM 345: 1177-1183 [Full Text]

Comments and questions? Please contact us.